Background: Brucellosis remains a significant zoonotic infection affecting approximately 500,000 people worldwide annually, with no licensed human vaccine available. Recombinant influenza virus vectors expressing Brucella spp. antigens represent a promising vaccine platform. However, transitioning from laboratory constructs to clinical candidates requires validation of scalable purification methods compliant with Good Manufacturing Practice (GMP) standards. This study aimed to develop and optimize a pilot-scale purification protocol for these vectors. Methods: Recombinant influenza A viruses (H5N1) expressing Brucella spp. antigens (Omp16, Omp19, L7/L12, Cu-Zn SOD) were propagated in MDCK cell culture. The optimized purification process included: (1) clarification; (2) ultrafiltration/diafiltration (100 kDa MWCO); (3) two-step chromatography (anion-exchange Q-Sepharose® Fast Flow and multimodal Capto™ Core 700); and (4) sterile filtration. Process validation was performed across three independent pilot-scale batches (20 L each). Results: The purification process demonstrated high reproducibility for all constructs. Final preparations met established quality criteria: infectious titer ≥ 5.2 log10 TCID50/mL, hemagglutination activity 7.33 ± 0.58–8.33 ± 0.58 log2, total protein content 157–305 μg/mL, residual host cell DNA < 10 ng/dose, and bacterial endotoxin levels ≤ 0.15 IU/mL. The overall recovery of infectious virus was 20–24%, an optimal value for multi-stage bioprocessing. Preservation of the target genetic insert was confirmed in all final preparations by PCR and sequencing. Conclusions: The developed integrated purification protocol yields vectors with high purification efficiency, preserving biological activity and meeting regulatory quality requirements for residual host cell DNA and endotoxins. The technological platform demonstrated versatility, robustness (inter-batch coefficient of variation for yield did not exceed 10–12%), and scalability, establishing a foundation for preclinical and clinical studies of candidate brucellosis vaccines.
Ticks are important vectors of pathogens affecting humans and animals, posing a serious threat to health. For the first time, we studied the metagenomic profile of the microbial composition of Hyalomma scupense and Hyalomma asiaticum ticks in Kazakhstan. For microbiome analysis, 94 adult H. asiaticum and H. scupense ticks collected from cattle in Kazakhstan in 2023 were randomly selected. 16S rRNA gene sequencing was performed using the Ion Torrent NGS platform. Taxonomic classification carried out in the BV-BRC platform with the Kraken2 database. Metagenomic analysis revealed 26 bacterial genera, including both pathogenic and symbiotic taxa. In H. scupense, the dominant groups were Francisella (89.0%), Staphylococcus (76.0%), and Candidatus Midichloria (61.0%), while in H. asiaticum they were Francisella (99.0% and 95.0%) and Helcococcus (65.0%). In male H. scupense, the proportion of Francisella reached 89%, whereas in females it varied from 2% to 28%. In H. asiaticum, Helcococcus accounted for 65% in males compared to 11% in females. This is the first report on the metagenomic profile of the microbiota of H. scupense and H. asiaticum in Kazakhstan. The detection of pathogens indicates a risk of their transmission to humans and animals and highlights the need to develop new tick control strategies.
Infectious bovine rhinotracheitis (IBR) is widespread and leads to significant economic losses in livestock farming. In Kazakhstan, cases of IBR in cattle are registered annually. Early identification and prevention of viral diseases are among the key tasks of veterinary safety in our country. Given the absence of domestically produced PCR test systems for the diagnosis of IBR in Kazakhstan, we have developed an effective real-time PCR test system for the detection of IBR, which enables rapid identification of the pathogen responsible for this disease. During the development of this test system, specificity parameters were determined using nucleic acids from heterologous bovine viruses, and analytical sensitivity was assessed using a series of 10-fold dilutions of plasmid DNA containing a specific insert of the gD gene fragment of the IBR virus. The detection limit was determined to be 1 copy of DNA per reaction. This level of sensitivity is effective and acceptable for use in diagnostic kits. The results of the laboratory studies demonstrated that the developed real-time PCR test system is highly sensitive and specific